# Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China

> **NCT00781716** · NA · UNKNOWN · sponsor: **Beijing Chao Yang Hospital** · enrollment: 1020 (estimated)

## Conditions studied

- Myocardial Infarction
- Coronary Artery Disease

## Interventions

- **DEVICE:** Drug eluting coronary stent system

## Key facts

- **NCT ID:** NCT00781716
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 1020 (ESTIMATED)
- **Last updated:** 2008-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781716, "Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00781716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*